Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2388)	4/29/2009 2:44:27 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CPHD was up 19.45% earlier, but is now up only 13.17% with volume now > 900Ks > its ADV The stock continues its near term up-trend that started on Friday. It traded earlier above the resistance at $10. <g> The next resistance levels are at $10.81 and $11.98 before it could get to test its Nov4 H at $15.70 <g> bigcharts.marketwatch.com Revenues in the last 2Qs have been lower and the 1stQ of 2009 showed a loss of $0.05 vs. $0.03 on the black in 2008 The estimated loss for 2009 is around $0.45/shr vs.$0/11/shr last Yr. But on Monday, it announced the release of its Xpert MTB/RIF under the European Directive on In Vitro Diagnostic Medical Devices,a rapid test that can simultaneously identify Mycobacterium tuberculosis and resistance to rifampicin.<g> And yesterday it announced that it will host its symposium, "Patient Management in the Era of Rapid Diagnostics" at the 19th European Congress of Clinical Microbiology and Infectious Diseases,in Finland next month. Bernard